According to the latest report by IMARC Group, titled “Safety Needles Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global safety needles market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/safety-needles-market/requestsample
A safety needle, also known as a safety syringe, has a built-in safety mechanism to minimize the risk of needlestick infection associated with healthcare provision. Needles can be a source of infection in several diseases, including Hepatitis B, D, and C, human immunodeficiency virus (HIV), etc. Safety needles are utilized in collecting fluids from the body and delivering drugs. They also protect patients and healthcare workers from hazardous drug exposure and bloodborne pathogens. Some commonly available needles include a cannula, pen, suture, biopsy, prefilled, intravenous, hypodermic, epidural, etc. At present times, automated pen needles with in-built safety features provide numerous benefits in insulin administration.
The increasing prevalence of chronic diseases and the elevating awareness towards numerous risk associated with conventional alternatives are driving the safety needles market across the globe. Furthermore, the rising adoption of prefilled syringes and the introduction of needle-based safety devices are catalyzing the market growth. Besides this, safety needles are used to reduce the risk of transmission of bloodborne viruses and protect patients from infection while administering COVID-19 vaccines, which is further augmenting the global market. Moreover, the implementation of various laws for safe injection practices by numerous health agencies is acting as another growth-inducing factor. Additionally, as these needles are cost-effective and minimize the incidences of iatrogenic injuries, the global market for safety needles will continue to experience growth in the coming years.
Safety Needles Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global safety needles market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Braun Melsungen AG
- Becton Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- Johnson & Johnson
- Nipro Corporation
- Novo Nordisk A/S
- Retractable Technologies Inc.
- Smiths Group plc
- Terumo Corporation
- Vygon
Key Market Segmentation:
The report has segmented the global safety needles market on the basis of product, application, end user and region.
Breakup by Product:
- Active Safety Needles
- Passive Safety Needles
- Others
Breakup by Application:
- Drug Delivery
- Sample Collection
- Injection
Breakup by End User:
- Hospitals and Ambulatory Surgery Centers
- Diabetic Patients
- Family Practice
- Psychiatry
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/safety-needles-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
